Search
for
Sort by
Research 931–960 of 1000+
- Scalp melanoma after antihair loss mesotherapy
- Breast Cancer-Related Neoplastic Alopecia: A Case Report and Review of the Literature
- Angelica Sinensis and Chinese Arborvitae: A Review on its Phytochemical & Pharmacological Importance
- Epithelial‐to‐mesenchymal transition in cutaneous wound healing: Where we are and where we are heading
- Aggressive Squamous Carcinomas of the Scalp
- Postoperative Radiotherapy for Cutaneous Squamous Cell Carcinoma in Patients With Microscopic Residual Disease
- Massive squamous cell carcinoma arising from hidradenitis suppurativa with marked hypercalcemia and neutrophilia
- Kemoterapinin En Görünen Yönü: Alopesi: Önlemek Mümkün Mü?
- The role of Kindlin-1 in skin homeostasis and tumor development
- Hair loss in the elderly
- Self Assessment
- MIM and Cortactin Antagonism Regulates Ciliogenesis and Hedgehog Signaling
- Vemurafenib-induced pityriasis amiantacea: a case report
- Desmoplastic melanoma presenting as primary alopecia neoplastica: a report of two cases
- 646 SOX4 is essential for melanoma tumorigenesis
- Beyond the Matrix: A Rare Case of Pilomatrix Carcinoma with Histologic Insights
- 200 Deep learning model to predict sentinel lymph node status in melanoma patients
- Molecular mapping of lymph node metastases by real-time reverse transcription polymerase chain reaction in two melanoma patients
- Trichomegaly of the eyelashes following treatment with cetuximab
- A distinct cutaneous reaction to sorafenib and a multikinase inhibitor
- Gene profile analysis of colorectal cancer cell lines by cDNA macroarray
- Cutaneous Crohn's disease treated with infliximab and 4 years of follow up
- Alopecia Areata Associated with Thymoma Presenting as a Diffuse Pleural Dissemination Mimicking Mesothelioma: Rare Concomitant Presentation
- Erlotinib-related Severe Hair Loss with Severe Exanthematous Drug Eruption: A Case Report
- Functional analysis of thymosin beta-4 using over-expressing transgenic mice
- Management of adverse events and other practical considerations in patients receiving capecitabine (Xeloda®)
- miR-22 promotes stem cell traits via activating Wnt/β-catenin signaling in cutaneous squamous cell carcinoma
- Incidence and management of cutaneous toxicities associated with cetuximab
- Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis
- Clinical Case Notes. Tamoxifen optic neuropathy